Adverse gastrointestinal effects of NSAIDs: consequences and costs
- 31 October 2001
- journal article
- review article
- Published by Elsevier BV in Best Practice & Research Clinical Gastroenterology
- Vol. 15 (5), 739-753
- https://doi.org/10.1053/bega.2001.0232
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Pharmacoepidemiology of non-steroidal anti-inflammatory drug use in Nottingham general practicesAlimentary Pharmacology & Therapeutics, 2000
- Current status of nonsteroidal anti-inflammatory drug (NSAID) use in the United States: risk factors and frequency of complicationsAmerican Journal Of Medicine, 1999
- Recent considerations in nonsteroidal anti-inflammatory drug gastropathyAmerican Journal Of Medicine, 1998
- Primary gastroduodenal prophylaxis with omeprazole for non‐steroidal anti‐inflammatory drug usersAlimentary Pharmacology & Therapeutics, 1998
- Nonsteroidal Anti-Inflammatory Drug-Induced Hepatic DisordersDrug Safety, 1996
- Nonsteroidal antiinflammatory drugs and dyspepsia in the elderlyDigestive Diseases and Sciences, 1995
- Severe Adverse Cutaneous Reactions to DrugsNew England Journal of Medicine, 1994
- The Ambiguous Relation between Aging and Adverse Drug ReactionsAnnals of Internal Medicine, 1991
- Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.Proceedings of the National Academy of Sciences, 1991
- EFFECT OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ON CONTROL OF HYPERTENSION BY BETA-BLOCKERS AND DIURETICSThe Lancet, 1986